The Legal Business Corporate and M&A Summit – 29 April 2019

Event times: 8.30am-5pm




At a glance

Legal Business is pleased to unveil our inaugural Corporate and M&A Summit in April 2019. The day-long discussion and networking event in central London will unite well over 100 in-house counsel, deal professionals, private practice lawyers and bankers focused on M&A and the wider world of corporate transactions to assess the issues defining the City.

Supported by our distinguished sponsors, including headline sponsor Latham & Watkins, the summit will form a best-in-class event from Legalease, one of the world’s top legal publishers. The initiative builds on the highly-successful launch earlier this year of our Financial Services Regulation and Banking Litigation Summit as well as our established one-day events for commercial litigation and arbitration.

Speakers and steering committee members include:

  • Nick Cline, Latham & Watkins
  • Nicole Kar, Linklaters
  • Samantha Thompson, Anglo American
  • Laura Anderson, Bristows
  • Simon Wood, Addleshaw Goddard
  • Jeremy Barton, KPMG
  • James Down, Smiths Group
  • Justin Stock, Cooley
  • Graham Kirk, HSBC
  • Fiona Adams, Greenberg Traurig
  • Marcus Young, King & Spalding
  • Olga Garcia, Cubico Sustainable Investments
  • James Kerton, London Stock Exchange Group
  • Claire Boydell, Arma Partners
  • Richard Butterwick, Latham & Watkins
  • Nick Johnston, Perella Weinberg Partners
  • Claudio Calcagno, Analysis Group
  • Jessie Gill, Stemcor
  • Paul Maher, Greenberg Traurig

Headline sponsor

Panel sponsors

Addleshaw Goddard Bristows Cooley
Greenberg Traurig King & Spalding Linklaters

Networking sponsor

The Venue:

The Brewery
52 Chiswell Street

To register please contact Craig Belson on

For more information please contact Lee Cashman on


Draft Agenda includes:



9.00am to 9.10am

Morning sessions:

M&A 3.0 – Smarter tactics for the modern deal team

A debate focused on recent advances in the process of M&A, including due diligence, risk mitigation/insurance cover, bridge financing and the latest trends from the US. How can you streamline your deal team?

The Takeover Panel – That crucial first week

The first few days in a potential bid are key in any fast-moving bid situation. We assess how the Takeover Panel will react in the key days of a potential bid from the perspective of both bidder and target. When must you go formal? What if you are bounced into an announcement? We also consider the impact of the controversial new regime to regulate foreign takeovers.

Big pharma, small partners – The key transactional trends in life sciences

We discuss the key trends and outlook facing the life sciences sector as big pharma adopts increasingly flexible means of acquiring, licensing and allying with know-how held by smaller partners. What deal techniques in pharma will be transitioning to other sectors?

Auctions – How to play the game

With auctions for hot assets an increasingly common feature of the European M&A scene, we ask how to make the process work for you. How to win. How to get the best out of the process. How to avoid overpaying. What are the tactics you need to know?

12.40pm to 1.30pm


Private equity – Building a portfolio

In an increasingly competitive race for assets, we assess how sponsors should approach building a portfolio. Where will the most attractive sectors and returns be in the next two years? And how should buyout houses mitigate their litigation risk across the portfolio?

Mobile assets – The risks and rewards of tech M&A

A debate exploring the particular challenges of buying IP-rich businesses. Covers how to manage increasingly fraught data issues and addressing the increasingly crucial due diligence process. Includes key trends in tech M&A and the latest from Silicon Valley.

Tougher competition – The growing impact of antitrust in marquee deals

With European antitrust policy increasingly in the headlines, big-ticket deals like Siemens/Alstom and Sainsbury’s/Asda facing competition hurdles, and deals like Qualcomm/NXP ditched amid foreign investment objections, we assess risk associated with major deals and focus on what deal teams can do to get their bid through.







London, United Kingdom